Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating AC607 for acute kidney injury in cardiac surgery was terminated. The snippet does not provide efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• AC607

Snippet

Sponsor: AlloCure Inc. | Conditions: Acute Kidney Injury | Phase 2 | Status: TERMINATED